Three preconference courses featuring pain medicine best practices, medications management, and ultrasound-guided pain interventions – as well as more than 50 AAPM 35th Annual Meeting sessions – make up AAPM35 March 6-10 in Denver. As an AAPM member, you receive discounted registration and access to special on-site benefits, like a Member Lounge an...
Pregabalin has beneficial effects on some symptoms of neuropathic pain. However, its use significantly increases the risk of a number of adverse events and discontinuation due to adverse events. The quality of the evidence from journal publications is low. Read the abstract .
This study identifies the association between direct-to-physician marketing of opioid products by pharmaceutical companies and mortality from prescription opioid overdoses across US counties. Read the abstract .
Findings identify carboxyl-terminal multisite phosphorylation as key step that drives acute μ-opioid receptor desensitization and long-term tolerance. Read the abstract .
There is still time to cast your vote before polls for the AAPM 2019-20 Leadership Elections close on Monday, February 4 . Active, voting members were sent an email from AAPM on January 4 with their unique voting link.
To encourage drug companies to enter the OTC market and increase access to naloxone, the FDA took an unprecedented step of developing a model Drug Facts label (DFL) with easy-to-understand pictograms on how to use the drug. Full story.
Clinical studies indicate that psychosocial stress contributes to adverse chronic pain outcomes in patients, but it is unclear how this is initiated or amplified by stress. Read the abstract .
This article describes the current consensus proposal by the International Association for the Study of Pain (IASP) and the International Society of Physical and Rehabilitation Medicine (ISPRM) for a specific set of FPs of chronic pain, which will have to be empirically validated in a next step. Read the abstract .
Chronic pain, defined as persistent or episodic pain that does not resolve with treatment, affects up to 50% of Veterans, costs the nation between $560 and $635 billion dollars annually, and is associated with high rates of disability and low quality of life. According to the Veterans Health Administration (VHA), the goal of pain treatment is to im...
A new study found a startling 250 percent increase in Americans taking a dangerous combination of both opioids and benzodiazepines — a group of drugs commonly prescribed for pain, insomnia and anxiety — over a 15-year period. Full story .